An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer

NCT00532194 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
486
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Medical Research Council

Collaborators